The Potential of Asiatic Acid in the Reversion of Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats.

Abstract

The purpose of this study was to determine if asiatic acid may act efficiently in the model of cyclophosphamide (CYP)-induced cystitis in rats. We performed experiments after administration of CYP (single dose 200 mg/kg, intraperitoneally), asiatic acid (30 mg/kg/day for 14 consecutive days, by oral gavage), or CYP plus asiatic acid, during which conscious cystometry, measurements of urothelium thickness and bladder edema, as well as selected biomarkers analyses were conducted. In rats that received asiatic acid together with CYP, a drop in bladder basal pressure, detrusor overactivity index, non-voiding contraction amplitude, non-voiding contraction frequency, and the area under the pressure curve were observed, when compared to the CYP group. Furthermore, a significant increase in threshold pressure, voided volume, intercontraction interval, bladder compliance, and volume threshold to elicit NVC were found in that group accordingly. Administration of the asiatic acid successfully restored concentrations of biomarkers both in bladder urothelium (BDNF, CGRP, OCT-3, IL-1β, IL-6, NGF, nitrotyrosine, malondialdehyde, TNF-α, SV2A, SNAP23, SNAP25, PAC-1, ORM1, occludin, IGFBP-3, HB-EGF, T-H protein, Z01, and HPX) and detrusor muscle (Rho kinase and VAChT) in CYP-treated rats. Finally, asiatic acid significantly decreased urothelium thickness and bladder oedema. Asiatic acid proved to be a potent and effective drug in the rat model of CYP-induced cystitis.

• Authors: Andrzej Wróbel, Łukasz Zapała, Tomasz Kluz, Artur Rogowski, Marcin Misiek, Kajetan Juszczak, Jacek Sieńko, Daniela Gold, Klaudia Stangel-Wójcikiewicz, Ewa Poleszak, Piotr Radziszewski
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 11 (May 29 2021) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 34072606 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents, Alkylating
• Biomarkers
• Pentacyclic Triterpenes
• Cyclophosphamide
• asiatic acid

Topics

• Animals
• Antineoplastic Agents, Alkylating (adverse effects)
• Biomarkers
• Cyclophosphamide (adverse effects)
• Cystitis (drug therapy, etiology)
• Disease Models, Animal
• Hemorrhage (drug therapy, etiology)
• Pentacyclic Triterpenes (pharmacology)
• Rats
• Urothelium (drug effects, metabolism, pathology)